SHS-4121705

N/A

Report date: 2024/11/07 16:30:19
NME

Base Information

Drug NameSHS-4121705
Drug Alias NameSHS-4121705
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteins modulators
TargetsProteins
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Virginia
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A